

Please try another search
Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's disease. The Company's product lines include Trappsol and Aquaplex. It sells its chemical products directly to customers in the pharmaceutical, diagnostics, and industrial chemical industries, and to chemical supply distributors. The Company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.
Name | Age | Since | Title |
---|---|---|---|
F. Patrick Ostronic | 65 | 2014 | Independent Vice Chairman |
Randall M. Toig | 70 | 2018 | Independent Director |
Markus Walter Sieger | 55 | 2014 | Independent Chairman |
N. Scott Fine | 64 | 2014 | CEO & Director |
Benny Liu | - | 2015 | Member of Scientific Advisory Board |
Gerald F. Cox | 62 | 2021 | Member of Scientific Advisory Board |
Caroline Hastings | - | 2015 | Member of Scientific Advisory Board |
William S. Shanahan | 82 | 2016 | Independent Director |
Rita R. Colwell | - | - | Co-Chair of Scientific Advisory Board |
Sharon H. Hrynkow | 62 | 2014 | Co-Chairman of Scientific Advisory Board |
C. E Strattan | 76 | 1990 | Founder & Director |
Jeffrey L. Tate | 64 | 2010 | COO, Chief Quality Officer & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review